These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10761952)

  • 1. The quality of anticoagulation management.
    Ansell JE
    Arch Intern Med; 2000 Apr; 160(7):895-6. PubMed ID: 10761952
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality of anticoagulation control in atrial fibrillation.
    Lane DA; Lip GY
    Lancet; 2010 Sep; 376(9745):935-7. PubMed ID: 20801499
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin K in anticoagulation therapy.
    Hanslik T; Viboud C; Chadenat ML; Jubault V; Prinseau J
    Lancet; 2001 Feb; 357(9256):637; author reply 638. PubMed ID: 11558516
    [No Abstract]   [Full Text] [Related]  

  • 5. At last, a RE-LYable alternative to warfarin for atrial fibrillation.
    Hankey GJ
    Int J Stroke; 2009 Dec; 4(6):454-5. PubMed ID: 19930055
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulation intensity for elderly atrial fibrillation patients: should we use a conventional INR target (2.0 to 3.0) or a lower range?
    Lane DA; Lip GY
    Thromb Haemost; 2010 Feb; 103(2):254-6. PubMed ID: 20076858
    [No Abstract]   [Full Text] [Related]  

  • 7. Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin.
    Mahtani KR; Nunan D; Heneghan C
    Heart; 2015 Nov; 101(21):1689-90. PubMed ID: 26135804
    [No Abstract]   [Full Text] [Related]  

  • 8. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of new oral anticoagulants in patients with atrial fibrillation previously treated with warfarin: a meta-analysis of randomized controlled trials.
    Fauchier L; Clementy N; Saint-Etienne C; Simeon E; Angoulvant D; Bernard-Brunet A
    Int J Cardiol; 2014 Apr; 173(1):122-4. PubMed ID: 24636544
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: CJ Green, DC Hadorn, K Bassett, A Kazanjian, Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. 1997;13:811-5.
    Mant MJ
    Can J Cardiol; 1998 May; 14(5):663; author reply 663, 665. PubMed ID: 9627519
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated international normalized ratio from vitamin K supplement discontinuation.
    Miesner AR; Sullivan TS
    Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 14. Barriers to the use of warfarin: potential solutions.
    McAnulty JH
    J Interv Card Electrophysiol; 2004; 10 Suppl 1():17-20. PubMed ID: 14739735
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.
    Giugliano RP; Ruff CT; Rost NS; Silverman S; Wiviott SD; Lowe C; Deenadayalu N; Murphy SA; Grip LT; Betcher JM; Duggal A; Dave J; Shi M; Mercuri M; Antman EM; Braunwald E;
    Stroke; 2014 Aug; 45(8):2372-8. PubMed ID: 24947287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible limitations of using the HAS-BLED bleeding score in real life settings.
    Gulec S
    Thromb Res; 2014 Jun; 133(6):959-60. PubMed ID: 24525313
    [No Abstract]   [Full Text] [Related]  

  • 17. Outpatient anticoagulation issues for the primary care physician.
    Spandorfer JM; Merli GJ
    Med Clin North Am; 1996 Mar; 80(2):475-91. PubMed ID: 8614182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin therapy for elderly persons with atrial fibrillation.
    Ackermann RJ
    Am Fam Physician; 1998 Jul; 58(1):45-6, 48-9. PubMed ID: 9672429
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thromboembolism in non-rheumatic atrial fibrillation].
    Pengo V
    Haematologica; 2001 Sep; 86(9 Suppl):5-11. PubMed ID: 11759619
    [No Abstract]   [Full Text] [Related]  

  • 20. Warfarin: better the devil you know.
    Blockman M
    Cardiovasc J Afr; 2017; 28(6):344-345. PubMed ID: 29297543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.